Findings show discomfort primarily exists among gynecologists seeing patients with a history of endometrial or epithelial ovarian cancer.

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV administration in the treatment of moderate to severe SLE.

The FDA has approved Bosaya and Aukelso, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

(HealthDay News) — Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is ...

Topline results were announced from a phase 3 head-to-head study comparing orforglipron with oral semaglutide in adults with ...

Cisplatin-based neoadjuvant chemotherapy typically improves outcomes for patients with muscle-invasive bladder cancer, but not all groups benefit.

(HealthDay News) — A new federal vaccine panel appointed by U.S. Health Secretary Robert F. Kennedy Jr. has recommended tighter restrictions on COVID-19 shots. The committee voted unanimously Friday ...

Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...

Certain patient-reported outcomes (PROs) can predict overall survival (OS) in patients with cancer, according to research published in JAMA Oncology. Researchers found that higher baseline scores in ...

(HealthDay News) — Bariatric surgery is associated with a significantly lower risk for developing major metabolic comorbidities compared with a medical weight management program for adults with ...

The Life Alliance Organ Recovery Agency, part of the University of Miami Health System, is one of 55 nonprofit organ procurement organizations (OPOs) in the United States. These groups recover organs ...

(HealthDay News) — Receiving remote behavioral urinary incontinence (UI) treatment through either a mobile health app or video visit improves symptoms among women veterans, according to a study ...